Exam Details
Subject | novel drug delivery system part-i | |
Paper | ||
Exam / Course | m.pharm | |
Department | ||
Organization | Gujarat Technological University | |
Position | ||
Exam Date | November, 2018 | |
City, State | gujarat, ahmedabad |
Question Paper
Seat No.: Enrolment No.
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Ph. SEMESTER-III • EXAMINATION WINTER -2018
Subject Code: 930102 Date:17/11/2018
Subject Name: Novel Drug Delivery System Part II
Time: 10:30AM TO 01:30PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Define Liposomes. Discuss the problems associated with liposomes drug delivery system.
06
Describe in brief the structure of Niosomes. Write about method of preparation of Niosomes.
05
Give pharmaceutical applications of polymers with example and discuss in brief about polymer characterization.
05
Q.2
Write a note on biodegradation of polymers.
06
Write a note on γ DNA technology.
05
Write a note on IIG status and impurity profile.
05
Q.3
What is SCF? State the challenges of SCF. Write about applications of SCF in pharmaceutical research.
06
Define "Pro-drug". Write a note on the prodrug approach.
05
Write about applications of hydrogel in drug delivery system.
05
Q.4
Define Sonophoresis. Give advantages of sonophoresis as a physical penetration enhancer.
06
Define disketts. Write a note on buccal disketts.
05
Explain electroosmosis and electrorepulsive with reference to ionophoresis.
05
Q.5
What is in-situ gel? Classify them and suggest its applications.
06
Differentiate strips/diskettes and films from their physical, chemical and therapeutic aspects.
05
Why intelligent drug delivery is important in recent Pharmaceutical Market?
Give outline to develop this drug delivery with suitable example.
05
Q. 6
What are standard and co-processed excipients? Discuss with suitable example.
06
Discuss the issues related to delivery of proteins and peptides. Write a short note on Immunomodulated molecules.
05
What is tailor-made medicine? Explain biomarkers in detail.
05
Q.7
Briefly explain the concept of PEGlylation. Give factors affecting performance of PEGlyted peptide. Discuss about manufacturing challenges.
06
Define nanotechnology. Discuss any one method of preparation of nanoparticle.
05
Write a note on Immunomodulated molecules.
05
GUJARAT TECHNOLOGICAL UNIVERSITY
M. Ph. SEMESTER-III • EXAMINATION WINTER -2018
Subject Code: 930102 Date:17/11/2018
Subject Name: Novel Drug Delivery System Part II
Time: 10:30AM TO 01:30PM Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Define Liposomes. Discuss the problems associated with liposomes drug delivery system.
06
Describe in brief the structure of Niosomes. Write about method of preparation of Niosomes.
05
Give pharmaceutical applications of polymers with example and discuss in brief about polymer characterization.
05
Q.2
Write a note on biodegradation of polymers.
06
Write a note on γ DNA technology.
05
Write a note on IIG status and impurity profile.
05
Q.3
What is SCF? State the challenges of SCF. Write about applications of SCF in pharmaceutical research.
06
Define "Pro-drug". Write a note on the prodrug approach.
05
Write about applications of hydrogel in drug delivery system.
05
Q.4
Define Sonophoresis. Give advantages of sonophoresis as a physical penetration enhancer.
06
Define disketts. Write a note on buccal disketts.
05
Explain electroosmosis and electrorepulsive with reference to ionophoresis.
05
Q.5
What is in-situ gel? Classify them and suggest its applications.
06
Differentiate strips/diskettes and films from their physical, chemical and therapeutic aspects.
05
Why intelligent drug delivery is important in recent Pharmaceutical Market?
Give outline to develop this drug delivery with suitable example.
05
Q. 6
What are standard and co-processed excipients? Discuss with suitable example.
06
Discuss the issues related to delivery of proteins and peptides. Write a short note on Immunomodulated molecules.
05
What is tailor-made medicine? Explain biomarkers in detail.
05
Q.7
Briefly explain the concept of PEGlylation. Give factors affecting performance of PEGlyted peptide. Discuss about manufacturing challenges.
06
Define nanotechnology. Discuss any one method of preparation of nanoparticle.
05
Write a note on Immunomodulated molecules.
05
Other Question Papers
Subjects
- advanced medicinal chemistry
- advanced organic chemistry-i
- advanced organic chemistry-ii
- advanced pharmacology ii
- advanced pharmacology-i
- advances in drug delivery system
- advances in pharmacology
- applied pharmacotherapeutics - ii
- applied pharmacotherapeutics-i
- audits and regulatory compliance
- biological evaluations & clinical research
- cellular and molecular pharmacology
- clinical and hospital pharmacy
- clinical pharmacy practice
- clinical research and pharmacy practice
- clinical research and regulatory affairs
- clinical research regulations
- cosmetic and cosmeceuticals
- documentation and regulatory writing
- drug design and discovery
- drug regulation and regulatory authority
- experimental design and patents
- global regulatory requirements
- gmp, glp and validation
- good manufacturing and good laboratory practice
- good manufacturing practice and process validation
- good regulatory practices
- hazards and safety management
- industrial pharmacy practice
- modern analytical techniques
- modern pharmaceutical analysis
- novel drug delivery system part-i
- novel drug delivery system-ii
- pharm. management -ii
- pharmaceutical analysis ii
- pharmaceutical and cosmetic analysis
- pharmaceutical formulation and development
- pharmaceutical formulation development and biopharmceutics
- pharmaceutical manufacturing technology
- pharmaceutical production management & technology
- pharmaceutical regulatory affairs
- pharmacological and toxicological screening methods-i
- pharmacological and toxicological screening methods-ii
- pharmacometrics and methods of biological evaluation of drugs
- pharmacotherapeutics
- principles of biopharmaceutics& pharmacokinetics
- product development and technology transfer
- quality control & quality assurance
- quality control and quality assurance
- quality management system
- regulatory affairs - i
- regulatory affairs and new drug applications
- regulatory aspects of hebbal and biologicals
- research methodology
- validation and product development